Emgrast 300 mcg Injection
13,12$
7,70$
Emgrast 300 mcg Injection is a synthetic version of human granulocyte colony-stimulating factor (G-CSF), specifically designed to enhance the production of white blood cells in individuals undergoing chemotherapy for cancer treatment. By stimulating the bone marrow, this medication plays a crucial role in boosting the immune system, thereby minimizing the risk of infections that often accompany chemotherapy. However, it is important to note that Emgrast is not suitable for patients with certain blood disorders, and its use should be closely monitored by healthcare professionals. Common side effects may include mild reactions at the injection site, headaches, or bone pain, but serious adverse effects are rare. Patients should inform their doctors about any existing medical conditions or medications to ensure safe use. With its targeted action and support for immune function, Emgrast offers vital assistance to those facing the challenges of cancer treatment. Always follow your healthcare provider’s instructions regarding dosage and administration to achieve the best possible outcomes.
Quantité
Active Pharmaceutical Ingredient
Uses
• Emgrast 300 mcg injection is primarily utilized in patients undergoing myelosuppressive chemotherapy for non-myeloid malignancies. This treatment helps reduce the risk of infections that may present as febrile neutropenia. By stimulating the production of white blood cells, Emgrast 300 mcg injection aids in bolstering the immune response during chemotherapy. This is particularly crucial when patients are at a heightened risk of severe neutropenia.
• In clinical settings, Emgrast 300 mcg injection is often administered to patients who are experiencing low white blood cell counts due to cancer treatments. By enhancing the recovery of neutrophil levels, it assists in minimizing the duration of neutropenia. This is vital for patients who require ongoing chemotherapy to manage their cancer effectively. The timely use of Emgrast 300 mcg injection can facilitate better treatment adherence and overall patient outcomes.
• Emgrast 300 mcg injection plays a significant role in preventing infections in patients with compromised immune systems due to cancer therapies. As these patients are more susceptible to infections, the injection helps improve their white blood cell counts and immune function. This is essential for maintaining health during intensive cancer treatment regimens. Utilizing Emgrast 300 mcg injection can lead to fewer interruptions in therapy and enhanced quality of life for these individuals.
• Healthcare providers often recommend Emgrast 300 mcg injection as part of the supportive care for cancer patients undergoing chemotherapy. This injection helps mitigate the complications associated with low white blood cell counts, such as febrile neutropenia. By ensuring a quicker recovery of neutrophils, Emgrast 300 mcg injection allows patients to continue their cancer treatments with reduced risk of infection. This proactive approach is critical in managing the side effects of chemotherapy and improving patient safety.
Benefits
Emgrast 300 mcg Injection is designed to stimulate the production of white blood cells, which are an important part of the body's immune system. By attacking and eliminating harmful bacteria and viruses, white blood cells help protect the body from infection and disease. By increasing the amount of white blood cells in the body.
Emgrast 300 mcg may help reduce the risk of infection in people with neutropenia. Neutropenia is a condition characterized by a low number of neutrophils, a type of white blood cell.
Emgrast 300 mcg Injection helps reduce the duration of neutropenia and neutropenia-related hospitalizations in people receiving chemotherapy for cancer. It may also be used to reduce the incidence of febrile neutropenia, which is a potentially serious complication of chemotherapy that is associated with fever and a low white blood cell count.
Overall, the main benefit of Emgrast 300 mcg Vial is its ability to help boost the body's immune system and protect it from infection.
Side Effects
Like all medicines, Emgrast 300 mcg may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Oropharyngeal pain
• Hair loss
• Fatigue
• Diarrhea
• Constipation
• Decreased appetite
• Cough
• Breathing problems
• Injection site reactions (pain, swelling, redness)
Common Side Effects
• Bone pain
• Weakness
• Headache
• Rash
• Nausea
• Increased lactate dehydrogenase level in blood
• Vomiting
• Increased uric acid level in the blood
How To Use
Emgrast 300 mcg Injection is administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of Filgrastim Injection 300 mcg will depend on the clinical condition of the patient's age and medical history and other factors. Kindly do not self-administer now.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Filgrastim Injection 300 mcg. May increase the risk of liver damage. It is best to avoid or limit alcohol consumption while taking medication.
• Kidney: The use of Emgrast 300 mcg Vial is safe in patients with kidney disease. No dose adjustment of Emgrast Injection is recommended. If you notice any side effects, contact your doctor.
• Breastfeeding: It is not known whether Emgrast Injection is excreted in breast milk. If you are breastfeeding and using Emgrast 300 mcg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing breastfeeding. Your doctor can help you make the best decision for you, your health and the health of your baby.
• Liver: Emgrast 300 mcg is safe to use in patients with liver disease. No dose adjustment of Filgrastim Injection 300 mcg is recommended. If you notice any side effects, contact your doctor.
• Pregnancy: The use of Emgrast 300 mcg Injection during pregnancy may not be safe, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the possible risks and benefits of using Emgrast 300 mcg Vial during pregnancy. Your doctor can help you make the best decision for you, your health and the health of your baby.
• Driving: Emgrast 300 mcg Injection is unlikely to affect your ability to drive or use machines. If you experience side effects such as dizziness or drowsiness while taking Emgrast 300 mcg, it is important not to drive a car or operate heavy machinery until the side effects have subsided.